Position in OGN
as of Mar 31, 2026
· filed Aug 18, 2026
Position Value
$83,614
-$16,472 QoQ
Shares Held
13,959
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $2,885,207,124 across 10 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
895,262 | $1,073,804,190 | |
| 2 | JNJ |
Johnson & Johnson
|
2,064,646 | $524,358,144 | |
| 3 | MRK |
Merck & Co., Inc.
|
3,364,831 | $432,380,783 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,940,617 | $245,177,551 | |
| 5 | ABBV |
AbbVie Inc.
|
861,436 | $216,771,755 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
2,865,663 | $165,119,502 | |
| 7 | PFE |
Pfizer Inc
|
5,127,377 | $123,467,238 | |
| 8 | AMGN |
Amgen Inc
|
236,929 | $85,796,729 |
All Filings in OGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $83,614 | 13,959 | Shares | Sole | 2026-08-18 | |
| 2025-12-31 | $100,086 | 13,959 | Shares | Sole | 2026-08-18 | |
| 2025-09-30 | $478,560 | 44,809 | Shares | Sole | 2026-08-18 | |
| 2025-06-30 | $520,387 | 53,759 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,027,544 | 69,009 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,029,614 | 69,009 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,320,142 | 69,009 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,428,486 | 69,009 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,297,369 | 69,009 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,045,305 | 72,490 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,258,426 | 72,490 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,508,516 | 72,490 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,917,115 | 81,510 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,176,249 | 77,918 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,888,263 | 80,695 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,627,606 | 77,855 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,012,363 | 86,240 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,001,326 | 65,725 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,740,092 | 114,062 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,190,564 | 270,673 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||